Great news, thanks Evaluate. That’s for the BATON system which cultures both dendritic cells and T-cells. Northwest Bio’s DCVax culturing process is a little different, but there’s aspects that this patent may cover in that process as well.
It will be interesting to see what becomes of this natural approach of using dendritic cells to introduce neoantigens to T-cells for a T-cell therapy, as opposed to engineering them.
Market Data 
Markets 
AI
